TY - JOUR
T1 - Pharmacokinetics and dosage planning of cefozopran in patients with renal insufficiency
AU - Takenaka, Tadasu
AU - Watanabe, Toyohiko
AU - Hayashi, Toshihide
AU - Hata, Kazuhiro
AU - Ono, Noriaki
AU - Kumon, Hiromi
AU - Ohmori, Hiroyuki
AU - Nanba, Katsuichi
AU - Kaneshige, Tetsuzou
AU - Ohmori, Hiroyuki
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1993
Y1 - 1993
N2 - We investigated pharmacokinetics of cefozopran (CZOP), a new cephem antibiotic, in patients with renal insufficiency. Serum levels of CZOP after a single administration were assayed by HPLC and urinary levels by Bioassay. 1) 1.0g CZOP were administered to healthy volunteers and patients with varying degrees of impaired renal function by 30minutes drip infusion. Pharmacokinetic parameters were determined using a two-compartment model. In healthy volunteers, the mean values of T1/2 (β) was 2.20h and β was 0.321/h. As proceeded the renal insufficiency, T1/2 (β) was prolonged and β was decreased. The mean urinary excretion rate within 24h was 70.0% in healthy volunteers and decreased to 32.5% in Patients with severe renal insufficiency whose creatinine clearrance (Ccr) were below 30ml/min. 2) To plan a regimen, β was selected as the parameter which varied in accordance with the degree of impaired renal function as measured by Ccr. A recommended dosing regimen in patients with renal insufficiency was studied.
AB - We investigated pharmacokinetics of cefozopran (CZOP), a new cephem antibiotic, in patients with renal insufficiency. Serum levels of CZOP after a single administration were assayed by HPLC and urinary levels by Bioassay. 1) 1.0g CZOP were administered to healthy volunteers and patients with varying degrees of impaired renal function by 30minutes drip infusion. Pharmacokinetic parameters were determined using a two-compartment model. In healthy volunteers, the mean values of T1/2 (β) was 2.20h and β was 0.321/h. As proceeded the renal insufficiency, T1/2 (β) was prolonged and β was decreased. The mean urinary excretion rate within 24h was 70.0% in healthy volunteers and decreased to 32.5% in Patients with severe renal insufficiency whose creatinine clearrance (Ccr) were below 30ml/min. 2) To plan a regimen, β was selected as the parameter which varied in accordance with the degree of impaired renal function as measured by Ccr. A recommended dosing regimen in patients with renal insufficiency was studied.
UR - http://www.scopus.com/inward/record.url?scp=0027718209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027718209&partnerID=8YFLogxK
U2 - 10.11250/chemotherapy1953.41.Supplement4_147
DO - 10.11250/chemotherapy1953.41.Supplement4_147
M3 - Article
AN - SCOPUS:0027718209
VL - 41
SP - 147
EP - 153
JO - Chemotherapy
JF - Chemotherapy
SN - 0009-3165
ER -